A new study published in the Journal of Oral Implantology reports that sinus membrane perforations most frequently occur during implant placement in crestal sinus elevation procedures. Researchers ...
Maxillary sinus augmentation remains a cornerstone intervention for addressing insufficient bone height in the posterior maxilla prior to dental implant placement. Techniques such as the lateral ...
Placed during a routine physician office visit, SINUVA expands in the sinus cavity and delivers an anti-inflammatory steroid directly to the site of polyp disease for up to 90 days. SINUVA was ...
With a multi-disciplinary approach, Fact.MR elaborates an extensive analysis of the historical, current and future outlook of the global Sinus Implants Market as well as the factors responsible for ...
Intersect ENT is launching its Sinuva Sinus Implant, a new approach to treating nasal polyp disease in adult patients who have had previous sinus surgery. The Menlo Park, CA-based company said nearly ...
Intersect ENT received CMS approval of a revised coding application for its Propel sinus implant, according to a Jan. 19 news release. Propel previously shared a billing code with Intersect ENT’s ...
MENLO PARK, Calif.--(BUSINESS WIRE)--Intersect ENT®, Inc. (Nasdaq: XENT), a global ear, nose and throat (“ENT”) medical technology leader dedicated to transforming patient care, today announced that ...
Lower health care utilization was shown in patients with chronic rhinosinusitis, with and without nasal polyps, who had steroid-eluting implants vs those who did not in the 18 months following ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results